Prudential PLC decreased its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 5.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 45,055 shares of the medical equipment provider's stock after selling 2,781 shares during the quarter. Prudential PLC's holdings in STERIS were worth $9,262,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. Franklin Resources Inc. increased its holdings in shares of STERIS by 171.2% during the third quarter. Franklin Resources Inc. now owns 838,569 shares of the medical equipment provider's stock valued at $191,370,000 after purchasing an additional 529,308 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its stake in STERIS by 30.8% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,970 shares of the medical equipment provider's stock valued at $2,275,000 after buying an additional 2,583 shares during the period. Wilmington Savings Fund Society FSB bought a new stake in shares of STERIS during the 3rd quarter worth about $9,949,000. Public Sector Pension Investment Board lifted its stake in shares of STERIS by 13.2% in the 3rd quarter. Public Sector Pension Investment Board now owns 4,283 shares of the medical equipment provider's stock worth $1,039,000 after acquiring an additional 500 shares during the period. Finally, Merit Financial Group LLC bought a new position in shares of STERIS in the fourth quarter valued at approximately $260,000. Institutional investors own 94.69% of the company's stock.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on STE. Needham & Company LLC restated a "hold" rating on shares of STERIS in a research report on Monday. JMP Securities reaffirmed a "market outperform" rating and set a $265.00 target price on shares of STERIS in a research note on Thursday. Piper Sandler boosted their price target on shares of STERIS from $260.00 to $265.00 and gave the stock an "overweight" rating in a research report on Monday, February 3rd. Finally, Stephens restated an "overweight" rating and set a $240.00 price objective on shares of STERIS in a research report on Thursday, February 6th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $258.75.
Check Out Our Latest Report on STERIS
STERIS Trading Down 3.0 %
NYSE STE traded down $6.60 on Thursday, hitting $216.34. 281,604 shares of the stock were exchanged, compared to its average volume of 535,839. The company's 50-day moving average price is $222.60 and its two-hundred day moving average price is $219.88. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.13 and a quick ratio of 1.40. STERIS plc has a 52-week low of $197.82 and a 52-week high of $248.24. The company has a market capitalization of $21.26 billion, a price-to-earnings ratio of 45.92 and a beta of 0.87.
STERIS (NYSE:STE - Get Free Report) last released its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Research analysts predict that STERIS plc will post 9.08 EPS for the current year.
STERIS Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, March 21st. Shareholders of record on Thursday, February 20th were given a dividend of $0.57 per share. The ex-dividend date was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.05%. STERIS's payout ratio is currently 48.41%.
About STERIS
(
Free Report)
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Recommended Stories
Before you consider STERIS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and STERIS wasn't on the list.
While STERIS currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
